79 related articles for article (PubMed ID: 20020536)
1. Pathogenic mutations cause rapid degradation of lysosomal storage disease-related membrane protein CLN6.
Kurze AK; Galliciotti G; Heine C; Mole SE; Quitsch A; Braulke T
Hum Mutat; 2010 Feb; 31(2):E1163-74. PubMed ID: 20020536
[TBL] [Abstract][Full Text] [Related]
2. Topology and endoplasmic reticulum retention signals of the lysosomal storage disease-related membrane protein CLN6.
Heine C; Quitsch A; Storch S; Martin Y; Lonka L; Lehesjoki AE; Mole SE; Braulke T
Mol Membr Biol; 2007; 24(1):74-87. PubMed ID: 17453415
[TBL] [Abstract][Full Text] [Related]
3. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein.
Mole SE; Michaux G; Codlin S; Wheeler RB; Sharp JD; Cutler DF
Exp Cell Res; 2004 Aug; 298(2):399-406. PubMed ID: 15265688
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis.
Teixeira CA; Espinola J; Huo L; Kohlschütter J; Persaud Sawin DA; Minassian B; Bessa CJ; Guimarães A; Stephan DA; Sá Miranda MC; MacDonald ME; Ribeiro MG; Boustany RM
Hum Mutat; 2003 May; 21(5):502-8. PubMed ID: 12673792
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis.
Thelen M; Damme M; Schweizer M; Hagel C; Wong AM; Cooper JD; Braulke T; Galliciotti G
PLoS One; 2012; 7(4):e35493. PubMed ID: 22536393
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis.
Sharp JD; Wheeler RB; Parker KA; Gardiner RM; Williams RE; Mole SE
Hum Mutat; 2003 Jul; 22(1):35-42. PubMed ID: 12815591
[TBL] [Abstract][Full Text] [Related]
7. Cln6 mutants associated with neuronal ceroid lipofuscinosis are degraded in a proteasome-dependent manner.
Oresic K; Mueller B; Tortorella D
Biosci Rep; 2009 Jun; 29(3):173-81. PubMed ID: 18811591
[TBL] [Abstract][Full Text] [Related]
8. High expression of disease-related Cln6 in the cerebral cortex, purkinje cells, dentate gyrus, and hippocampal ca1 neurons.
Thelen M; Fehr S; Schweizer M; Braulke T; Galliciotti G
J Neurosci Res; 2012 Mar; 90(3):568-74. PubMed ID: 22012656
[TBL] [Abstract][Full Text] [Related]
9. Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A.
Heine C; Koch B; Storch S; Kohlschütter A; Palmer DN; Braulke T
J Biol Chem; 2004 May; 279(21):22347-52. PubMed ID: 15010453
[TBL] [Abstract][Full Text] [Related]
10. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
[TBL] [Abstract][Full Text] [Related]
11. Transport, enzymatic activity, and stability of mutant sulfamidase (SGSH) identified in patients with mucopolysaccharidosis type III A.
Muschol N; Storch S; Ballhausen D; Beesley C; Westermann JC; Gal A; Ullrich K; Hopwood JJ; Winchester B; Braulke T
Hum Mutat; 2004 Jun; 23(6):559-66. PubMed ID: 15146460
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis.
Bartsch U; Galliciotti G; Jofre GF; Jankowiak W; Hagel C; Braulke T
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6952-9. PubMed ID: 24084090
[TBL] [Abstract][Full Text] [Related]
13. Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells.
Lonka L; Salonen T; Siintola E; Kopra O; Lehesjoki AE; Jalanko A
J Neurosci Res; 2004 Jun; 76(6):862-71. PubMed ID: 15160397
[TBL] [Abstract][Full Text] [Related]
14. Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin.
Hofmann S; Bauer MF
FEBS Lett; 2006 Jul; 580(16):4000-4. PubMed ID: 16806192
[TBL] [Abstract][Full Text] [Related]
15. A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.
Morgan JP; Magee H; Wong A; Nelson T; Koch B; Cooper JD; Weimer JM
PLoS One; 2013; 8(11):e78694. PubMed ID: 24223841
[TBL] [Abstract][Full Text] [Related]
16. Protein product of CLN6 gene responsible for variant late-onset infantile neuronal ceroid lipofuscinosis interacts with CRMP-2.
Benedict JW; Getty AL; Wishart TM; Gillingwater TH; Pearce DA
J Neurosci Res; 2009 Jul; 87(9):2157-66. PubMed ID: 19235893
[TBL] [Abstract][Full Text] [Related]
17. CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.
Rusyn E; Mousallem T; Persaud-Sawin DA; Miller S; Boustany RM
Pediatr Res; 2008 Jun; 63(6):625-31. PubMed ID: 18317235
[TBL] [Abstract][Full Text] [Related]
18. Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway.
Tsukuba T; Kadowaki T; Hengst JA; Bond JS
Arch Biochem Biophys; 2002 Jan; 397(2):191-8. PubMed ID: 11795871
[TBL] [Abstract][Full Text] [Related]
19. Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).
Fujita E; Kouroku Y; Isoai A; Kumagai H; Misutani A; Matsuda C; Hayashi YK; Momoi T
Hum Mol Genet; 2007 Mar; 16(6):618-29. PubMed ID: 17331981
[TBL] [Abstract][Full Text] [Related]
20. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation.
Crystal AS; Morais VA; Fortna RR; Carlin D; Pierson TC; Wilson CA; Lee VM; Doms RW
Biochemistry; 2004 Mar; 43(12):3555-63. PubMed ID: 15035625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
